Nanomaterials News

RSS

U.S. Investment Arm of Tokyo Electron Invests Additional Capital into Unidym

Unidym, a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), announced today that TEL Venture Capital, Inc., the U.S. investment arm of Tokyo Electron, has invested additional capital into the co...

3 Dec 2008

NanoDynamics CEO to Present at First Nanotechnology International Forum

NanoDynamics, Inc. announced today that the company's CEO, Keith Blakely, will present at the first Nanotechnology International Forum on December 3-5 in Moscow, organized by the Russian Corporation of Nanotechnologies (RUSNANO).

2 Dec 2008

Handheld Device that Finds Even Faint Signs of Cancer in Blood Sample

A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.

2 Dec 2008

Selah Technologies Receives SBIR Grant to Accelerate Commercialization of Selah Dots

Selah Technologies, an advanced materials manufacturer, announced today that the company has received a $100,000 SBIR Phase I grant from the National Science Foundation (NSF) to fund continued manufacturing and developme...

2 Dec 2008

ConocoPhillips and KU Announces Three-Year Collaborative Nanotechnology Research Program

ConocoPhillips and the University of Kansas (KU) today announced a three-year collaborative nanotechnology research program which will focus on the development and testing of new technologies for oilfield stimulation to ...

2 Dec 2008

Nanotechnology Will Provide Superior Implants for Orthopaedic Patients

A brand new process that could revolutionise the reliability and durability of surgical implants, such as hip and knee replacements, has today, 2 December 08, received recognition for its medical and commercial potential...

2 Dec 2008

Using Magnetic Nanotechnology to Spot Cancer-Associated Proteins

The detection of cancer-associated proteins, or biomarkers, in blood samples is a potentially powerful tool for early diagnosis of cancer and monitoring of cancer treatment. A team led by researchers at Stanford University and the University of California, Santa Cruz, has developed a compact prototype detector that uses magnetic nanotechnology to spot cancer-associated proteins in a human blood serum sample with much higher sensitivity than current detectors.

2 Dec 2008